Agency of the United States Department of Health and Human Services
POPULARITY
Categories
357 episodes with fda
281 episodes with fda
183 episodes with fda
247 episodes with fda
229 episodes with fda
126 episodes with fda
183 episodes with fda
112 episodes with fda
147 episodes with fda
150 episodes with fda
273 episodes with fda
183 episodes with fda
178 episodes with fda
185 episodes with fda
53 episodes with fda
82 episodes with fda
75 episodes with fda
90 episodes with fda
65 episodes with fda
62 episodes with fda
135 episodes with fda
55 episodes with fda
70 episodes with fda
107 episodes with fda
107 episodes with fda
61 episodes with fda
68 episodes with fda
36 episodes with fda
96 episodes with fda
44 episodes with fda
50 episodes with fda
65 episodes with fda
44 episodes with fda
42 episodes with fda
105 episodes with fda
43 episodes with fda
64 episodes with fda
50 episodes with fda
47 episodes with fda
51 episodes with fda
61 episodes with fda
97 episodes with fda
78 episodes with fda
41 episodes with fda
38 episodes with fda
59 episodes with fda
64 episodes with fda
56 episodes with fda
55 episodes with fda
97 episodes with fda
73 episodes with fda
59 episodes with fda
49 episodes with fda
99 episodes with fda
In this sweeping exposé, the host weaves together a narrative of corruption, cover-ups, and collusion across America's most critical institutions. Revisiting the controversial claims of Sidney Powell, he traces how early warnings of Chinese counterfeit ballots and identity theft—once scorned as conspiracy theories—are now partly confirmed by recent FBI admissions of massive document smuggling tied to TikTok. He details how coordinated censorship by Big Tech preemptively stifled debate on election integrity, while federal agencies allegedly destroyed evidence. The conversation then pivots to the food and water Americans consume daily, condemning the FDA, EPA, and corporate giants for pumping artificial dyes and fluoride into products linked to cancer and neurological damage. From the manipulation of the census and gerrymandering to efforts by RFK Jr. and Ron DeSantis to purge toxins from the marketplace, the segments paint a picture of a country under siege—not only at the ballot box but also at the dinner table. This is a call to vigilance: the stakes are nothing less than public health, democratic legitimacy, and the future of the nation.
In this week's Digital Health Roundup, MedTech Insight's Marion Webb discusses her interview with Johns Hopkins researcher Axel Krieger who published study findings on autonomous surgery. Brian Bossetta highlights new FDA cybersecurity guidance and Medtronic's partnership with IRCAD to train surgeons on robots. Shubham Singh highlights his interviews with OpenWater on stroke and EnsoData on sleep. Natasha Barrow discusses FDA approval challenges with Flow Neuroscience's CEO. Tags: robotics, robotic surgery, FDA, cybersecurity, cardiology, neurology, leadership interviews, neurostimulation, commercial, medtech.
I love aging and also… I get botox. I love my laugh lines (obviously, we named our podcast after them) but I also want to age gracefully. I want to feel like the best version of myself as I get older and sometimes… that means I get a little help from someone with a laser and a medical degree. In this episode of Laugh Lines, we're pulling back the curtain on cosmetic procedures with my very own dermatologist (and not a paid spokesperson!), the amazing Dr. Sue Ellen Cox. Too many people whisper about this stuff when it should be okay to talk about it!In the show, we discuss botox, lasers, fillers, necks, jowls, and even something called “pre-juvenation.” Dr. Cox is a legend in the field—like "clinical trials for the FDA" kind of legend. This episode is for anyone who's botox-curious, laser-curious, or simply wondering what all this stuff actually does. No gatekeeping here—we're being honest about what we've tried and what questions to ask. Be sure to stay tuned for the Oxford comma justice and Gen Z slang confusion this week. Apparently “he cooked” doesn't mean he made dinner, according to our son. (PC even makes an appearance at the end of the show!) We love to hear from you, leave us a message at 323-364-3929 or write the show at podcast@theholdernessfamily.com. You can also watch our podcast on YouTube.Learn more about Dr. Sue Ellen Cox and Aesthetic Solutions: https://aesthetic-solutions.com/Visit Our ShopJoin Our NewsletterFind us on SubstackFollow us on InstagramFollow us on TikTok Follow us on FacebookLaugh Lines with Kim & Penn Holderness is an evolution of The Holderness Family Podcast, which began in 2018. Kim and Penn Holderness are award-winning online content creators known for their original music, song parodies, comedy sketches, and weekly podcasts. Their videos have resulted in over two billion views and over nine million followers since 2013. Penn and Kim are also authors of the New York Times Bestselling Book, ADHD Is Awesome: A Guide To (Mostly) Thriving With ADHD and winners on The Amazing Race (Season 33) on CBS. Laugh Lines is hosted and executive produced by Kim Holderness and Penn Holderness, with original music by Penn Holderness. Laugh Lines is also written and produced by Ann Marie Taepke, and edited and produced by Sam Allen. It is hosted by Acast. Thanks for listening! Hosted on Acast. See acast.com/privacy for more information.
BONUS EP FROM LAST MONTH, PLUS MEMBERS GET NEW ROUNDUPS EVERY MONDAY, SIGN UP AT GRIMERICAOUTLAWED.CA Is the Black Eye club at play? What about the secret space program... hints of John Dee and Enochian Magic. Or the Judas Protocol? Breaking news about CDC and RFK Jr, dismantling the vaccine committee, new two year study showing the failure of the FDA and the majority of drugs. Does Elon really have all the spaceships? Is MAGA to blame for LA Riots? Program insiders might be summoning again.. Greta's boat boarded by the IDF. Phones in the water. What did the founder of Telegram tell Tucker about the USA Gov? Support and extra content http://www.grimericaoutlawed.ca/support. Substack and Subscribe. https://grimericaoutlawed.substack.com/ or to our Locals https://grimericaoutlawed.locals.com/ or Rokfin www.Rokfin.com/Grimerica Patreon https://www.patreon.com/grimericaoutlawed Support the show directly: https://grimericacbd.com/ CBD and THC Tinctures and Gummies! https://grimerica.ca/support-2/ http://Grimerica.ca/shrooms and Micro Dosing The Eh-List YouTube Channel: https://youtube.com/@theeh-list?si=d_ThkEYAK6UG_hGX Our Adultbrain Audiobook Podcast and Website: www.adultbrain.ca Our Audiobook Youtube Channel: https://www.youtube.com/@adultbrainaudiobookpublishing/videos Darren's book www.acanadianshame.ca Check out our next trip/conference/meetup - Contact at the Cabin www.contactatthecabin.com www.grimerica.ca/Shrooms and Micro-Dosing Other affiliated shows: www.grimerica.ca The OG Grimerica Show www.Rokfin.com/Grimerica Our channel on free speech Rokfin Join the chat / hangout with a bunch of fellow Grimericans Https://t.me.grimerica https://www.guilded.gg/chat/b7af7266-771d-427f-978c-872a7962a6c2?messageId=c1e1c7cd-c6e9-4eaf-abc9-e6ec0be89ff3 Leave a review on iTunes and/or Stitcher: https://itunes.apple.com/ca/podcast/grimerica-outlawed http://www.stitcher.com/podcast/grimerica-outlawed Sign up for our newsletter http://www.grimerica.ca/news SPAM Graham = and send him your synchronicities, feedback, strange experiences and psychedelic trip reports!! graham@grimerica.com InstaGRAM https://www.instagram.com/the_grimerica_show_podcast/ Purchase swag, with partial proceeds donated to the show www.grimerica.ca/swag Send us a postcard or letter http://www.grimerica.ca/contact/ ART - Napolean Duheme's site http://www.lostbreadcomic.com/ MUSIC Tru Northperception, Felix's Site sirfelix.bandcamp.com Links to the stuff we chatted about: https://x.com/OMApproach/status/1932059888122753337 https://x.com/DataRepublican/status/1932105886241378456 https://x.com/covertress/status/1931768944786129187 https://x.com/UAPWatchers/status/1930964205802278914 https://x.com/AmurakaHidden/status/1930767977055506871 https://www.instagram.com/p/DKabdjzotdS/ https://palexander.substack.com/p/did-i-not-tell-you-this-in-a-prior?utm_source=post-email-title&publication_id=579356&post_id=165420260&utm_campaign=email-post-title&isFreemail=true&r=24pqe&triedRedirect=true&utm_medium=email https://naomiwolf.substack.com/p/brian-and-naomi-in-the-lair?utm_source=post-email-title&publication_id=676930&post_id=165564236&utm_campaign=email-post-title&isFreemail=true&r=24pqe&triedRedirect=true&utm_medium=email https://apnews.com/article/kennedy-cdc-acip-vaccines-3790c89f45b6314c5c7b686db0e3a8f9 https://x.com/free_bythesea/status/1931979525941789071?s=43 https://x.com/vigilantfox/status/1932178912265609498?s=43
What does it mean to keep wisdom ahead of rapidly advancing technology? In this episode of Today's Conversation, Max Tegmark, professor and AI researcher at MIT and co-founder of the Future of Life Institute, explores the urgent question of how society can ensure artificial intelligence empowers — rather than endangers — human flourishing.In this episode, Max Tegmark joins NAE President Walter Kim to unpack the profound opportunities and alarming risks posed by AI. Drawing on vivid analogies, historical lessons and real-world examples, they examine why the stakes for wisdom, foresight and moral courage have never been higher.In their conversation, they discuss:Why wisdom must stay ahead of technology's power — and what happens when it doesn't;How past successes in safety engineering, like airbags and the FDA, offer a roadmap for responsible AI development;The urgent need for faith communities to raise AI as a moral issue, not just a technical one; andHow re-centering the conversation on stewardship and responsibility can shift priorities toward the common good.Subscribe today wherever you listen to podcasts.Do you like the podcast?Give us a 5-star rating on Apple Podcasts and leave us a review. This is the best way for others to discover these conversations. If you listen on Spotify, give us a follow and hit the notification bell to be sure you never miss an episode. And don't forget to pass your favorite episodes along to colleagues, friends and family.Resources“Life 3.0: Being Human in the Age of Artificial Intelligence” by Max Tegmark The Future of Life Institute Redemptive Artificial Intelligence, NAE podcast with Andy Crouch You Are Not a Machine, Spring/Summer 2025 edition of Evangelicals magazine
Thinking about hormone replacement therapy but unsure what's right for you? In this episode of the Paloma Health podcast, we're diving deep into bioidentical hormone replacement therapy (BHRT)—a treatment option that's gaining attention for being more aligned with your body's natural chemistry. You'll learn what bioidentical hormones actually are, how they differ from traditional synthetic hormones, and why many experts consider them a gentler and potentially safer alternative.We'll break down the science behind BHRT, focusing on commonly used hormones like estradiol and progesterone that are chemically identical to those your body naturally produces. We also explore why the delivery method—especially transdermal options like patches or gels—matters for both effectiveness and safety, potentially reducing the risk of blood clots, heart disease, and breast cancer compared to oral synthetic hormone therapies.But not all BHRT is created equal. This episode also tackles the controversy around compounded bioidentical hormones, which are custom-made by specialty pharmacies but not FDA-approved. We explain the concerns around quality control, dosing consistency, and regulation—while also acknowledging that for some people, compounded formulations may be necessary.If you're navigating perimenopause or menopause, this episode will help you better understand your options. LEARN MOREYou can learn more about how bioidentical hormone replacement therapy in an in-depth article at the Paloma Health blog. https://www.palomahealth.com/learn/is-bioidentical-hrt-safer-more-effective ABOUT PALOMA HEALTH Paloma Health is an online medical practice focused exclusively on treating hypothyroidism. From online visits with your provider to easy prescription management and lab orders, we create personalized treatment plans for you. Become a member, or try our at-home test kit and experience a whole new level of hypothyroid care. Use code PODCAST to save $30 at checkout.Disclaimer: The $30 discount is only valid for first-time Paloma Health members and test kit users. Coupon must be entered at the time of checkout. Become a Paloma Member:https://www.palomahealth.com/pricing-hypothyroidism Paloma Complete Thyroid Blood Test Kit:https://www.palomahealth.com/home-thyroid-blood-test-kit
#WHATSHAPPENING – He attempted to evade responsibility for killing his family. There's a significant flood threat on the East Coast, and the FDA has approved a new food dye. Additionally, there is a trend related to Zin, and there's a new purpose being found for feral cats. Participating in just 30 minutes of "Japanese walking" each day may help improve your fitness. Audiobook narrators are grappling with the rise of robot narrators, with one noting, "AI doesn't know what an orgasm sounds like." Predictions are also being made for the 2025 Emmy nominations.
What if we could have all the immune-boosting benefits of raw milk without any of the safety risks? That's the promise of today's episode.Bob Comstock is the CEO of Tamarack Biotics and inventor of a revolutionary UV pasteurization technology that just received FDA approval after 12 years of development. Unlike traditional heat pasteurization that destroys up to 70% of milk's beneficial compounds, Bob's "cold pasteurization" process preserves 93-100% of bioactive proteins while eliminating dangerous pathogens.European studies have consistently shown that children who consume raw milk are protected from developing asthma, hay fever, eczema, and food allergies – conditions that now affect nearly half of all children. But the scientific community has confirmed that heating milk destroys this protective effect. Bob's UV technology could be the key to making these health benefits safely accessible to everyone.Bob shares the fascinating origin story of how he discovered this technology while living in Singapore, the hundreds of pathogens they had to test against for FDA approval, and why a regulation from the 1970s nearly derailed the entire project. He also discusses their clinical trials showing elderly participants had 120% more antibodies after consuming UV-treated milk protein compared to traditional whey protein, and their upcoming studies on allergy prevention in children.This technology could revolutionize not just the dairy industry, but potentially help address America's chronic disease epidemic by making truly nutritious milk widely available for the first time in over 150 years.About Bob ComstockBob Comstock is the founder and CEO of Tamarack Biotics, a food‑tech company based in Fresno, California. With a Mechanical Engineering degree from UC Berkeley, Bob launched Tamarack in 2011 to pioneer healthier dairy solutions. Before starting Tamarack Biotics, he started Compass Foods, which developed the world's most water soluble food grade emulsifier. Under his leadership, Tamarack developed TruActive®, the first FDA‑accepted UV‑based milk treatment that kills pathogens while retaining enzymes, proteins, and immune‑boosting bioactives—without traditional pasteurization.Discounts Get 10% off delicious local farm-fresh food delivered to your door with my link for FarmMatch: https://farmmatch.com/jane Get 15% off high-quality Italian olive oil with code FARMTOFUTURE: https://shop.vignolifood.com/FARMTOFUTURE Get 40% the CircleDNA's Premium DNA test with code JANEZHANG: https://circledna.com/premium Connect with Jane Z. Instagram: @farm.to.future Email: jane@farmtofuture.co Website: farmtofuture.co
In this follow-up episode of The Headache Doctor Podcast, Dr. Taves sits down with Steve Marchese, CEO of LightStim, to dive deeper into the science and health benefits of red light therapy. Building on last week's discussion, this episode focuses on how FDA-cleared LightStim technology supports natural relief from headaches and migraines—while also benefiting the body as a whole. Discover how red light therapy fits into a medication-free approach to healing, and learn why LightStim is leading the way in safe, effective, at-home treatment.
S4:E179 David offers the latest insights into venture and then Paul interviews Leigh Hsu, CEO of Atticus Pharma, a specialist BioTech Startup focused on Immunodermatology therapeutics. Atticus is utilizing a unique proprietary sustained-release skin delivery technology to address 2 specific skin conditions for which there is no good treatment. Atticus was spun out of Zylo Therapeutics who developed the skin drug delivery technology that Atticus is using for FDA regulated candidate drugs, one for cutaneous Lupus and the other for Alopecia (localized hair loss). (interview recorded 6.11.25)Follow David and Paul: https://x.com/DGRollingSouth https://x.com/PalmettoAngel Connect On LinkedIn: https://www.linkedin.com/in/davidgrisell/ https://www.linkedin.com/in/paulclarkprivateequity/ We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com. Learn more about RollingSouth at rollingsouth.vc or email david@rollingsouth.vc.
Chinese biotech is the lone bright spot for the biopharma financial markets in 1H25, as macro concerns about the most favored nation (MFN) pricing policy and FDA weigh on the prospects for biotech elsewhere. On the latest BioCentury This Week podcast, BioCentury's analysts discuss the positives — and negatives — impacting investor sentiment headed into the second half of the year. The team also discuss where the quantum computing revolution could have its biggest impact on drug development, and review the proposals and accomplishments of FDA Commissioner Marty Makary over his first 100 days in office.View full story: https://www.biocentury.com/article/#biotech #biopharma #pharma #lifescience #financialmarkets #FDA #quantumcomputingReach us by sending a text
In today's episode, supported by Thermo Fisher Scientific, we had the pleasure of speaking with Apar Kishor Ganti, MD; and Allison Cushman-Vokoun, MD, PhD, FCAP, about the FDA approval of the Oncomine DX Express Test for use as a companion diagnostic for sunvozertinib (Zegfrovy) in EGFR exon 20 insertion mutation–positive non–small cell lung cancer and for use in tumor profiling. Dr Ganti is a professor in the University of Nebraska Medical Center (UNMC) Division of Oncology & Hematology, the Dr. and Mrs. D. Leon UMNC Research Fund Chair in Internal Medicine, and the associate director for Clinical Research at the Fred & Pamela Buffett Cancer Center in Omaha. Dr Cushman is the Henry F. Krous Professor of Pathology, a professor in the UNMC Department of Pathology, Microbiology and Immunology, director of the Division of Diagnostic Molecular Pathology and Human Genetics, medical director of the Molecular Diagnostics and Personalized Medicine Laboratory at Nebraska Medicine, director of the Molecular Genetic Pathology Fellowship Program, and associate director of the UMNC MD-PhD Scholars Program. In our exclusive interview, Drs Ganti and Cushman discussed the significance of the launch of the Oncomine DX Express Test, the benefits and limitations of rapid next-generation sequencing, and features that set Oncomine DX apart from other available tests.
In this episode, our new host, Randee Donovan, sits down with Annelieke Van Ooij, Product Development Director, and Alex Brewer, Regulatory Affairs Director, as they guide us through all things product reformulation. From increased synthetic dye bans and ongoing FDA updates, shifting regulations are forcing brands to rethink their product formulation. Our experts break down today's evolving regulatory landscape and provide technical guidance that will help you formulate without compromising on taste.
The FDA is unraveling. Scientists are being fired, vaccine access is shrinking, and top researchers are fleeing the country. And at the center of the storm? RFK Jr.'s appointees—Marty Makary and Vinay Prasad—men who once sat behind keyboards criticizing pandemic policy, now wield real power with devastating results. In this week's episode, Jonathan and Wendy walk us through the chaos: from dismissals without explanation to fabricated claims about who's being laid off, to the surreal moment when the very people who told us COVID was like the flu are now deciding who gets vaccinated. They call out journalist John Tierney for whitewashing pandemic history and expose the hypocrisy of pundits who cheered on herd immunity while vilifying actual public health officials. This isn't just a takedown—it's a warning. When contrarians become the establishment, science doesn't just get silenced. It gets rewritten. The FDA is unraveling. Scientists are being fired, vaccine access is shrinking, and top researchers are fleeing the country. And at the center of the storm? RFK Jr.'s appointees—Marty Makary and Vinay Prasad—men who once sat behind keyboards criticizing pandemic policy, now wield real power with devastating results. In this week's episode, Jonathan and Wendy walk us through the chaos: from dismissals without explanation to fabricated claims about who's being laid off, to the surreal moment when the very people who told us COVID was like the flu are now deciding who gets vaccinated. They call out journalist John Tierney for whitewashing pandemic history and expose the hypocrisy of pundits who cheered on herd immunity while vilifying actual public health officials. This isn't just a takedown—it's a warning. When contrarians become the establishment, science doesn't just get silenced. It gets rewritten. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/ The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only. The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information. The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content. The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content. Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer. Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has rejected Capricor's therapy for Duchenne Muscular Dystrophy (DMD), causing shares to plunge due to insufficient evidence of effectiveness for cardiomyopathy associated with DMD. Lilly and Sarepta also received Complete Response Letters (CRLs) for their therapies. Moderna has won full approval for its COVID-19 vaccine for higher-risk kids, while Pacira has cut staff in San Diego. The FDA has released a cache of CRLs, providing insights into the journeys to market for various drugs. AbbVie has acquired Ichnos Glenmark's lead myeloma antibody, and Ultragenyx's stock plummeted after a late-stage trial disappointment. Kennedy postponed a preventive care panel meeting after a Supreme Court win. Transitioning from one piece of news to the next, let's move on to the webinar exploring digitization strategies for drug development. Stay tuned for more updates in the pharmaceutical industry.
Following the FDA approval of taletrectinib (Ibtrozi) for patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer (NSCLC), CancerNetwork® spoke with Jorge Nieva, MD, about how this regulatory decision may impact the treatment paradigm for this disease. The approval was supported by findings from the phase 2 TRUST-I trial (NCT04395677) and the phase 2 TRUST-II trial (NCT04919811). The total efficacy population included 157 patients who had no prior treatment with a ROS1 tyrosine kinase inhibitor (TKI) and 113 who were previously treated with a ROS1 TKI. Topline results showed an objective response rate (ORR) of 90% (95% CI, 83%-95%) in TRUST-I and 85% (95% CI, 73%-93%) in TRUST-II among patients who had no prior treatment. Of those with pretreated disease, the respective ORRs were 52% (95% CI, 39%-64%) and 62% (95% CI, 46%-75%) in each study population. According to Nieva, an associate professor of clinical medicine at the Keck School of Medicine of the University of Southern California, taletrectinib may offer advantages over other therapies in the ROS1-positive metastatic NSCLC space based on its improved central nervous system (CNS) toxicity profile and “excellent” response and progression-free survival data. He stated that taletrectinib would become the go-to first-line agent in his practice. Additionally, he discussed strategies for mitigating toxicities related to taletrectinib such as nausea and diarrhea, and highlighted the need for additional research to improve immunotherapy options in NSCLC. “I'm very happy that we have choices for patients, and I'm very happy that we have such a wide variety of drugs, but we still need to do better, and we need to find better ways of using these agents because they're still not cures for the majority of patients,” Nieva stated. “While these drugs can be helpful at debulking tumors, we still need to do a lot more work [to do] on making this a disease of the past for those patients who have it.” Reference FDA approves taletrectinib for ROS1-positive non-small cell lung cancer. News release. FDA. June 11, 2025. Accessed July 8, 2025. https://tinyurl.com/yc4f379m
We all have favorite snacks, drinks, and fast food treats that we love. However, every so often, those treats get discontinued for some reason or other. As a fond remembrance of foods past, Geek Salad is bringing you episode 257: The FDA's Secret Restricted Warehouse of Lost Foods. Join Andy, Mike, Joe, and Katherine (as well as the participators in their live stream) as they go over some of their favorite tasty treats of ages past. From Wendy's baked potato bar to Jolt Cola, they go over some of the items which satisfied their taste buds but have since been consigned to that big walk-in freezer in the sky. Did they unearth some fond memories for you? Geek Salad is available at www.geeksalad.podbean.com, or can be subscribed to at the iTunes store by using keyword “geek salad.” Geek Salad is also available on Spotify,iTunes, iHeart Radio and wherever else you get your podcasts! Also, check out the Podbean App where you can stream and download the entire Geek Salad archive right from your Android or iPhone! You can get the app at either the Google Play Store or the Apple App Store! Want Geek Salad swag? Check out our new store on Tee Public, where you can get t-shirts, mugs, stickers, and so much other stuff!!! Shop here! Geek Salad episodes are now also available to stream on YouTube. “Like” and Subscribe to their channel at Geek Salad Podcast at www.youtube.com Contact Geek Salad at geeksaladradio@gmail.com. Geek Salad is also available on Facebook under the group heading “Geek Salad Podcast.” Check out their website at www.geek-salad.com, and please subscribe to their Twitter/X, Threads, and Blue Sky feeds: @geeksaladradio Geek Salad is intended for adult listeners and contains coarse language and profanity. Listener discretion is advised.
Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for June 30-July 6, 2025: Sebetralstat FDA-Approved as First Oral, On-Demand for Hereditary Angioedema The FDA approved sebetralstat (Ekterly) on July 7, 2025, as the first oral, on-demand treatment for hereditary angioedema attacks in patients aged 12 and older, backed by phase 3 KONFIDENT trial data. Rilparencel Improves eGFR Slope in Phase 2 CKD, Diabetes REGEN-007 Trial Rilparencel significantly slowed kidney function decline in CKD patients with diabetes in the REGEN-007 trial, showing dose-responsive eGFR slope improvements after two injections per kidney. J&J Submits sNDA to FDA for Lumateperone (CAPLYTA) to Prevent Schizophrenia Relapse J&J filed a supplemental NDA for lumateperone after phase 3 data showed a 63% reduction in schizophrenia relapse risk compared to placebo. FDA Publishes CRLs for Past Drug, Biological Product Applications The FDA publicly released over 200 Complete Response Letters from 2020–2024 to increase regulatory transparency and help accelerate future drug approvals. FDA Grants TSND-201 Breakthrough Therapy Designation for PTSD TSND-201 (methylone) received Breakthrough Therapy designation for PTSD on July 10, 2025, offering a potential rapid-acting alternative to SSRIs, which can take up to 12 weeks for full effect.
ProPublica’s Megan Rose details how the FDA is failing to properly police generic drugs in your medicine cabinet. Wired’s Steven Levy examines the big tech executives now working within the U.S. Army.See omnystudio.com/listener for privacy information.
On this episode of Vitality Radio, Jared is joined by Dr. Christine Schaffner, a leading naturopathic doctor specializing in chronic illness and post-COVID recovery. They dive into the complex realities of long COVID and vaccine injury—why symptoms like brain fog, fatigue, neuropathy, and immune issues are on the rise, and how spike protein may be playing a major role. Dr. Schaffner shares real clinical insights, key lab tests, and practical strategies using a variety of tools like methylene blue, systemic enzymes, mitochondrial support, and vagus nerve therapy. If you or a loved one is still struggling after COVID or the vaccine, this conversation offers both answers and hope.Products Discussedalso:Oral Peptides: BPC157 & KPV (Call to order 801-292-6662)Additional Information:Dr. Christine Schaffner - websiteDr. Christine Schaffner - IGVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
In his weekly clinical update, Dr. Griffin with Vincent Racaniello note that history is being rewritten for justification of changes in COVID vaccine guidelines including myocarditis incidence and the Great Barrington Declaration ignoring presentations at the April 2025 ACIP, the response by the medical community to these changed guidelines, before Dr. Griffin discusses how vaccination associates with reduced dementia risk before deep diving into recent statistics on measles epidemic, RSV, influenza and SARS-CoV-2 infections the Wasterwater Scan dashboard, a potential new influenza antiviral durg, whether or not the NB.1.8.1 should be included in the fall 2025 vaccines, immunization recommendations for COVID-19 vaccines, where to find PEMGARDA, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, associaton of remesdivir administration and long-term sequelae and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode FDA to look again at myocarditis risk from mRNA-based COVID-19 jabs in young men (FirstWord PHARMA) Great Barrington Declaration (Great Barrington Declaration) Debunking Herd Immunity: A Review of We Want Them Infected (Global Autoimmune Institute Scientific consensus on the COVID-19 pandemic (LANCET) John Snow, memo vaccines-plus strategy (John Snow Memorandum) This CDC Resignation Should Scare You (Substack: Beyond the Noise) COVID-19–Associated Hospitalizations — COVID-NET, April 2025 Update (CDC: National Center for Immunization and Respiratory Diseases) Leading Medical Professional Societies, Patient Sue HHS, Robert F. Kennedy, Jr. for Unlawful, Unilateral Vaccine Changes (ACP: American College of Physicians) Medical groups sue HHS, Kennedy over COVID vaccine policy changes(CIDRAP) Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections (Vaccines) Influenza vaccination reduces dementia risk (Ageing Research Reviews) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) New Mexico announces measles outbreak in a county detention facility(AP News) Weekly measles and rubella monitoring (Government of Canada) Measles vaccine recommendations from NYP (jpg) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza (CIDARA Therapeutics) Experimental flu drug may protect better than flu vaccines(CIDRAP) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Readmission Following Respiratory Syncytial Virus Hospitalization among Children
Interstellar visitor July 2025, runaway inflation leading to hyperinflation, exploding U.S. debt, A.I surveillance and the FDA's approval of lab grown salmon. What does this mean for global food systems and how we move through the changing landscape? ☕ Buy a Double Espresso to Support Civilization Cycle Podcast
In this week's Fraud Friday, Laci is joined by Sara Levine & Danny Murphy (Not Another True Crime Podcast) to discuss Elizabeth Swaney, who proudly made it to the 2018 PyeongChang Winter Games, without doing a single trick in her sport. Plus, the FDA demanded Alex Jones stop advertising questionable dietary supplements as coronavirus treatments, threatening legal action if he didn't stop. Stay Schemin'! (Originally Released 06/06/2022) CON-gregation, catch Laci's TV Show, Scam Goddess, now on Freeform and Hulu!Did you miss out on a custom signed Scam Goddess: Lessons from a Life of Cons, Grifts and Schemes book? Look no more, nab your copy here on PODSWAG Follow on Instagram:Scam Goddess Pod: @scamgoddesspodLaci Mosley: @divalaciSara Levine: @saralememeDanny Murphy: @kashmeredanny Research by Kaelyn Brandt SOURCES:https://everything-everywhere.com/elizabeth-swaney-and-the-power-of-just-showing-up/https://olympics.com/en/news/elizabeth-swaney-unlikely-halfpipe-herohttps://resumes.actorsaccess.com/elizabethhttps://www.theguardian.com/us-news/2019/apr/21/elizabeth-swaney-olympics-skiing-american-ninja-warriorhttps://www.cbssports.com/olympics/news/mikaela-shiffrin-doesnt-have-anything-to-prove-to-anyone-at-the-beijing-olympics/ Subscribe to SiriusXM Podcasts+ to listen to new episodes of Scam Goddess ad-free and a whole week early. Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus.
Dr. Reedy welcomes Dr. Alexa Altman where she discusses how psychedelics bring the unconscious material into consciousness. She talks about the importance of integration. Dr. Altman's Website: https://www.i-psychedelic.com 1. Single-dose psilocybin (25 mg) with psychological support for MDDJAMA – “Single-Dose Psilocybin Treatment for Major Depressive Disorder” psychiatryonline.org+15sunstonetherapies.com+15pmc.ncbi.nlm.nih.gov+15 Summary: Demonstrated strong antidepressant effects and good tolerability over follow-up. Email: info@hopkinspsychedelic.org 2. One-Year Follow-Up of Psilocybin for Depression Study: Long-term effects of psilocybin therapy for depression Johns Hopkins – “Psilocybin treatment for major depression effective for up to a year” Summary: 67% of participants remained in remission one year post-treatment. 3. MDMA-Assisted Therapy for Severe PTSD Randomized, placebo-controlled MDMA-assisted therapy Nature Medicine – “MDMA-assisted therapy for severe PTSD” Summary: Significant reduction in PTSD symptoms, well‑tolerated in a diverse cohort. Contact (MAPS / Lykos Therapeutics): Email: info@maps.org 4. Psilocybin for Cancer-Related Anxiety & Depression Psilocybin in patients with life-threatening cancer PMC – “High-dose psilocybin produced large decreases in depressed mood and anxiety…” Summary: 80% of participants maintained significant symptom relief at 6 months. Website: heffter.org (contact via site) en.wikipedia.org 1. Johns Hopkins University Center for Psychedelic and Consciousness Research Psilocybin for depression, anxiety, addiction, and end-of-life distress Why it's top-tier: The first major U.S. institution to receive regulatory approval for psychedelic research in modern times.
Broadcast from KSQD, Santa Cruz on 7-10-2025: Dr. Dawn responds to an email about lion's mane mushroom blood thinning properties. Lion's mane contains hericenones that inhibit platelet aggregation but promote nerve cell growth. People on blood thinners like Eliquis or those with bleeding disorders should stop these supplements before surgery. She recommends lion's mane for cognitive preservation effects despite bleeding risks, emphasizing the need to balance benefits versus risks. An emailer asks about Fatty15 (C15:0 pentadecanoic acid) supplements marketed for longevity. Dr. Dawn finds promising research, however, most studies are in animals with limited human data. She warns against over-supplementation and recommends food-first approaches, suggesting cheaper alternatives like berberine may provide similar benefits. A visiting guest asks about continuing L-arginine after blood pressure normalized. Dr. Dawn recommends continuing L-arginine as it helps produce nitric oxide and prevents age-related arterial stiffening. She explains how blood vessel elasticity decreases with age, creating feed-forward cycles leading to permanent hypertension. The guest also asks about iodine safety - Dr. Dawn confirms 1mg daily is safe, noting Japanese populations consume up to 4mg daily without problems. Another visiting guest inquires about memory-boosting supplements (nootropics). Dr. Dawn identifies nicotine and caffeine as effective options, mentioning she uses nicotine patches for test-taking focus. She discusses lion's mane as effective for cognitive enhancement and coffee blends combining both ingredients. A caller asks about tirzepatide (Mounjaro) for weight loss at age 73, concerned about muscle loss. Dr. Dawn emphasizes the importance of branched-chain amino acids and 20-30 grams of protein before exercise for older adults to build muscle protein. She explains younger people can build muscle while fasting, but older adults need circulating protein during exercise to activate muscle-building DNA. She recommends alternating upper and lower body workouts and checking testosterone levels. Another caller asks about rapid resting pulse rate (80-100 bpm) at age 74. Dr. Dawn suggests checking blood pressure, as low blood pressure can cause compensatory heart rate increases. She explains age-related changes in blood vessel reflexes that can cause blood pooling in legs and orthostatic changes. The caller also complains about pharmaceutical advertising, prompting Dr. Dawn to criticize direct-to-consumer drug marketing for creating artificial needs through emotional manipulation. Dr. Dawn warns against P-Tau217 blood testing for Alzheimer's screening, calling it inadequate for general population screening. The test has poor predictive value below level 10, creating many false positives in low-risk populations. She criticizes associated drugs like donanemab (Kisunla) for severe side effects including brain swelling and hemorrhage. Instead, she recommends lifestyle interventions: exercise, stress control, adequate sleep, reduced alcohol and sugar intake for memory concerns. She criticizes FDA approval of a new blood test for colon cancer screening with 83% sensitivity for detecting existing cancers but poor sensitivity for precancerous polyps. Dr. Dawn criticizes this as inadequate screening since it detects cancer after "the horse has left the barn" rather than preventing it. In closing remarks with her impromptu guests, Dr. Dawn addresses a question about intermittent fasting and exercise timing. She explains that exercising while fasting provides cardiovascular benefits but won't build muscle mass in older adults. She recommends bioimpedance analysis testing to track lean body mass annually in seniors and emphasizes the importance of progressive resistance training to prevent age-related muscle loss.
In this enlightening episode of The Birth Lounge podcast, HeHe dives into the world of skincare during pregnancy with nurse practitioner Claire O'Bryan, founder of The Skin Clique. They explore the surprising fact that most skincare ingredients are not regulated by the FDA and discuss what it truly means for a product to be 'clean'. They tackle common pregnancy skincare concerns such as melasma, acne, and the safety of popular ingredients like retinoids and salicylic acid. The episode also touches on the controversial topics of Botox, fillers, and the efficacy of supplements like collagen in skincare. Claire provides practical advice on crafting an effective, simple daily skincare routine and the importance of sunscreen, while addressing misconceptions about the need for sunscreen. Tune in to get evidence-based answers to your burning skincare questions and learn how to navigate the complexities of beauty products safely in pregnancy and beyond. 00:00 Introduction to Skincare Safety 02:00 Common Skincare Concerns During Pregnancy 03:50 Interview with Claire O'Bryan 04:51 Skincare Regimens and Fads 07:20 Pregnancy-Safe Skincare Ingredients 11:06 Acne Treatments During Pregnancy 15:33 Retinol Alternatives and Supplements 20:37 Daily Skincare Routine Essentials 25:16 Sunscreen Myths and Facts 34:51 Effective Sunscreen Reapplication 35:42 Blue Light Protection in Sunscreens 36:32 Impact of Screen Time on Skin 38:39 Understanding Botox and Fillers 44:32 Botox Safety During Pregnancy and Nursing 50:36 Microneedling and Skincare During Pregnancy 01:01:34 Preventing and Treating Stretch Marks 01:06:18 Conclusion and Final Thoughts Guest Bio: Claire O'Bryan is a dynamic nurse practitioner and entrepreneur dedicated to empowering women and amplifying the voices of female healthcare leaders globally. Her mission extends beyond traditional medical aesthetics – she's reshaping how we think about healthcare delivery while paving the way for women in leadership. As the co-founder of Skin Clique, Claire continues to help revolutionize the medical aesthetics industry through a groundbreaking concierge model. Since launching Skin Clique in 2019, what began as a vision for more accessible skin health has grown into a nationwide network of 1,000 skilled providers across 43 states. This expansion reflects not just business success but a transformation in how people access professional treatments and skincare. It is the modern approach to skin health. INSTAGRAM: Connect with HeHe on IG Connect with Claire on IG BIRTH EDUCATION: Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience: https://www.thebirthlounge.com/ Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone: https://www.thebirthlounge.com/app-download-page LINKS MENTIONED: www.claireobryan.com www.skinclique.com: Use code Claire10 for a discount! Pregnancy safe skincare: https://shopmy.us/collections/549485 Collagen meta analysis: https://pmc.ncbi.nlm.nih.gov/articles/PMC10180699/?utm_source ACOG https://www.acog.org/womens-health/faqs/toxic-chemicals-steps-to-stay-safer-before-and-during-pregnancy ACOG Skin Conditions https://www.acog.org/womens-health/faqs/skin-conditions-during-pregnancy Retinol VS Bakuchiol in a double blind RCT https://pubmed.ncbi.nlm.nih.gov/29947134/ Systematic Review of Retinol VS Bakuchiol https://pubmed.ncbi.nlm.nih.gov/36176207/ Collagen https://pmc.ncbi.nlm.nih.gov/articles/PMC10180699/
In America, body weight has become a pain point shrouded in self-recrimination and shame, not to mention bias from the medical community. For many, this battle not only takes a mental toll but also becomes a physical threat: three-quarters of American adults struggle with weight-related health conditions, including high blood pressure, heart disease and diabetes. We know that diets don't work, and yet we also know that excess weight starves us of years and quality of life. Where do we go from here? This evening, Dr. David Kessler will discuss some key points from his new book, Diet, Drugs and Dopamine, which unpacks the mystery of weight in the most comprehensive work to date on this topic, giving readers the power to dramatically improve their health. About the Speakers Dr. David Kessler is a prominent figure in public health, medicine and academia. He served as the commissioner of the FDA from 1990 to 1997, making significant contributions to drug approval, food safety and consumer protection. He is also a professor of pediatrics and epidemiology at the University of California, San Francisco. Additionally, he has served as dean of the Yale School of Medicine and the UCSF School of Medicine. The moderator is Anahad O'Connor. He is a health columnist who writes about food and nutrition for The Washington Post's Well+Being desk. Anahad joined the Post in 2022; before that, he was a staff reporter for The New York Times, where he spent two decades covering health and science. A Nutrition, Food & Wellness Member-led Forum program. Forums at the Club are organized and run by volunteer programmers who are members of The Commonwealth Club, and they cover a diverse range of topics. ORGANIZER: Patty James Learn more about your ad choices. Visit megaphone.fm/adchoices
What if artificial intelligence could help save your erections during prostate cancer surgery?In this groundbreaking episode of the Dr. Geo Prostate Podcast, Dr. Geo sits down with world-renowned urologist and sexual health pioneer Dr. Arthur "Bud" Burnett from Johns Hopkins. Together, they discuss an exciting new frontier in men's health: using AI and intraoperative neuromonitoring to preserve erectile function during prostate cancer surgery.Dr. Burnett shares his four decades of experience and explains how advanced techniques — including real-time nerve mapping and AI-guided signals during surgery — are transforming outcomes for men. Imagine a future where surgeons can “see” and protect the exact nerves critical for erections, like having a GPS guiding them in real time.They also dive into:✅ The evolution of erectile dysfunction treatments — from Yohimbine to Viagra and beyond✅ The history and future of penile implants, including the possibility of app-controlled devices✅ Why nerve-sparing techniques alone may not be enough to preserve function after prostatectomy✅ How AI and precision medicine are changing surgical outcomes and offering men more hopePlus, Dr. Burnett discusses upcoming clinical trials and how men can potentially participate today at Johns Hopkins.
In this episode, Chris Paul and Ghost dissect the week's most controversial stories, starting with the DOJ's decision to file an antitrust statement of interest against the Trusted News Initiative. They explain how RFK Jr.'s Children's Health Defense lawsuit accuses Big Tech and legacy media of colluding to censor dissent and shut out competitors. The conversation shifts to the FDA's approval of Moderna's Spikevax shot for young children, sparking outrage over continued mandates for a virus the hosts argue was always exaggerated. They dive into the chaos at Elon Musk's X platform, where Grok AI versions 3 and 4 ignited firestorms by spouting antisemitic rants about Israel, prompting CEO Linda Yaccarino's abrupt resignation. With perfect timing, the meltdown coincided with Netanyahu's tense visit to Washington and a flood of speculation about orchestrated psyops. The show also explores how AI censorship works across every topic, from election narratives to health policy, and why Substack and Twitter have become the new fronts for narrative warfare. On the geopolitical side, they break down Trump's move to hand weapons to NATO rather than Ukraine, Israel's internal power struggles, and Europe's hollow nuclear threats. Packed with humor and big-picture analysis, this episode challenges every official storyline.
July 11, 2025. Richard Small, CEO of Neurotech, talks to host Ben Shaberman about ENCELTO™, the first and only FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2 (MacTel). The therapy is a tiny, implantable capsule, the size of a rice grain, that delivers neurotrophic factors to preserve the patient's retinal cells and vision. The approach was previously developed to treat retinitis pigmentosa and age-related macular degeneration.
Episode 197: Continuous Glucose MonitoringWritten by William Zeng, MSIII, and Chris Kim, MSIII. University of Southern California.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Will: IntroToday we're exploring Continuous Glucose Monitoring, or CGM. We'll break down what CGM is, who benefits, how to access it, options available for our patients, the pros and cons, and a few final reflections on where this technology is heading. Chris, So what is CGM?Chris:Continuous glucose monitoring refers to the use of a small wearable sensor placed just under the skin to track glucose levels in real time throughout the day and night. These sensors measure glucose in the interstitial fluid and transmit readings to a receiver or smartphone at regular intervals, allowing for 24/7 glucose trend tracking. Will:CGM has been shown to improve glycemic control, increase “time in range,” and reduce hypoglycemia. Let's review some evidence.Chris:A 2023 meta-analysis published in Diabetes Technology & Therapeutics reported a mean Hemoglobin A1c reduction of 0.43% across multiple trials. Will:In people with Type 1 diabetes, the IMPACT and DIAMOND studies showed sustained improvement in Hemoglobin A1c and hypoglycemia reduction over 6–12 months. CGM use in insulin-treated Type 2 diabetes patients also resulted in significant benefits, including reduced variability and fewer severe glucose excursions. Chris:Clinically and economically, CGMs help prevent long-term complications such as cardiovascular disease, nephropathy, and retinopathy. Chris, What patients specifically benefit the most from CGM?Will: CGMs are most commonly indicated for people with Type 1 diabetes and for those with Type 2 diabetes who are using intensive insulin regimens—typically defined as multiple daily injections or insulin pump therapy. Chris:And what are the qualifications in order to be covered by insurance?Will:In the United States, Medicare covers CGM as durable medical equipment for qualifying patients, and coverage requires a prescription, documentation of insulin use, and regular follow-up. Most major private insurers—including Blue Cross, Aetna, UnitedHealthcare, Cigna, and Kaiser—follow similar guidelines. Coverage is generally granted for patients with Type 1 diabetes or insulin-requiring Type 2 diabetes who monitor glucose at least four times daily or use an insulin pump. Chris:Some plans require demonstration of hypoglycemia unawareness or frequent glucose variability. For patients not on insulin, OTC CGMs may be an option, but coverage is typically not provided. That said, new FDA decisions are allowing over-the-counter access to CGMs like Abbott's FreeStyle Libre and Dexcom's Stelo, expanding availability for lifestyle or preventive purposes.Will:[There are a lot of products on the market. Which are the main products and how are they different?]Chris:The three main players in the CGM space are Dexcom, Abbott (FreeStyle Libre), and Senseonics (Eversense), each with unique offerings.Let's start with Dexcom. Dexcom G7 is a real-time CGM system approved for both Type 1 and Type 2 diabetes. It combines a sensor and transmitter into one compact wearable patch worn on the abdomen or upper arm for up to 10 days. It updates glucose readings every 5 minutes and connects directly to a smartphone or Apple Watch via Bluetooth. Dexcom also integrates with insulin pumps like Tandem's t:slim and the Omnipod 5. Data can be shared with providers through Dexcom Clarity, which integrates into electronic medical records (EMRs) like Epic. OTC access is not yet available for DEXCOM G7, but a new non-prescription product called Dexcom Stelo is being rolled out in 2025, targeting non-insulin-using Type 2 patients. Dexcom Stelo will also offer 15-day wear, smartphone integration, and factory calibration. The estimated OTC cost for Dexcom Stelo is expected to be around $99 for a 15-day sensor, or about $198/month.Will:$200! Abbott FreeStyle Libre comes in several versions. The Libre 2 offers 14-day wear and requires users to scan the sensor with their smartphone or reader to retrieve a glucose value. It has optional real-time alarms for high and low readings and transmits data to LibreView, which can integrate with most EMRs. Libre 3 is a real-time CGM with 1-minute interval updates, Bluetooth transmission, and a slimmer profile. Libre sensors are widely used in primary care and available OTC for non-insulin users. Libre 2 sensors cost approximately $70–$85 for a 14-day sensor, while Libre 3 is slightly higher, around $85–$100 per sensor—totaling about $140–$200/month out of pocket without insurance.Chris:Senseonics Eversense E3 is the only implantable CGM on the market. It involves a minor in-office procedure to insert the sensor under the skin of the upper arm, which lasts up to 180 days (and a newer version, Eversense 365, lasts up to one year). A removable transmitter worn on top of the skin sends data every 5 minutes to a mobile app and vibrates for alerts. It requires 1–2 calibrations per day using a traditional fingerstick meter. It integrates with Eversense DMS software for physician monitoring. The total cost for Eversense depends on the insertion procedure and insurance, but cash pay for the full 6-month system is estimated at $2,400–$3,000, or about $400–$500/month including follow-up visits.Will:Additional lower-cost CGMs such as the Medtrum A6 TouchCare are available internationally and in select U.S. pilot programs. These devices offer 14-day wear, smartphone syncing, and daily calibration, but are not yet FDA-approved for wide use and lack full EMR integration.Chris:In terms of performance and value, Dexcom G7 offers the most advanced real-time feedback and integration, making it ideal for those on insulin pumps or needing tight control. Will:FreeStyle Libre offers the best affordability and convenience, especially for non-insulin users or those who prefer not to deal with constant alerts. Eversense offers a niche but compelling option for people who want to avoid frequent sensor changes. Chris, [Are there any downsides or risks that patients should be aware of before trying out CGM?]Chris:CGMs are generally safe and well-tolerated, but they do have limitations. Dexcom G7 has a known failure mode where sensors sometimes fail prematurely, often before the full 10-day duration. Some users have reported “signal loss” errors or random disconnections, especially when switching between phone models or operating systems. There are occasional reports of inaccurate highs or lows due to compression during sleep or dehydration. Though the G7 is factory-calibrated, abrupt changes in hydration or blood flow can affect its readings.Will:FreeStyle Libre systems, particularly Libre 2, require the user to scan the sensor to retrieve data unless alerts are enabled. These devices may be affected by vitamin C (ascorbic acid), which can falsely elevate glucose readings, and they do not currently allow for automated insulin delivery integration. Some Libre 2 users have noted adhesive-related rashes or spontaneous detachment. Libre 3, while more advanced, still may lose Bluetooth connection intermittently, particularly if the phone is out of range or the app is not running in the background.Chris:Senseonics Eversense carries procedural risks due to its implantable nature. Minor scarring or infection at the insertion site has been reported. The transmitter must be worn during waking hours to provide alerts, and users report anxiety over losing the transmitter since data logging is interrupted without it. Calibration is still required, which adds to daily tasks. Additionally, the sensor does not communicate with insulin pumps or closed-loop systems.Will:All CGMs can cause mild skin irritation from adhesive, particularly in users with sensitive skin. Alert fatigue is another consideration, as frequent low- or high-glucose warnings may cause stress or lead users to silence notifications entirely. Finally, relying solely on CGM without periodic fingerstick confirmation in symptomatic scenarios can be a risk, especially during rapid glucose changes.Chris:Conclusion[***] Continuous glucose monitors have reshaped the way we manage diabetes, offering unprecedented insight into glucose trends, diet responses, and insulin timing. While CGMs are not flawless, the technology continues to evolve. Will: If your patient is on insulin or struggling with glucose variability, consider whether CGM is right for your patient. For those not using insulin, consider newer OTC options like FreeStyle Libre or Dexcom Stelo, which offer accessible entry points without the need for prescriptions. As AI integration, longer sensor life, and non-invasive monitoring enter the market, CGM will only become more useful.Dr Arreaza: Personal experience with CGMs. I do not have diabetes, but I have a strong family history of diabetes (including father, 2 grandmas, and about 15 uncles, aunts, and cousins.)I wanted to try it so I could teach my patients about CGM. My first experience was with Freestyle Libre 2: Pros: Painless placement, easy to use, scanning with phone was easier than fingersticks.Cons: Required some assembling to be placed, mild discomfort at night, and nighttime alarms.Dexcom G7:Pros: No need for scanning, feels more stable in your armCons: High readings (had to calibrate for a more accurate reading)Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.
Mei Yung - Ageless Zen Skincare On the Value of Safe Skincare: "It's not about so much about vanity, but having healthy skin." Maintenance free is what we all seem to want. But with some things, we don't get that option. Our skin, that we do not get a second chance with, is one of those things we need to maintain in order to keep healthy. Mei Yung Lee, the founder and CEO of Ageless Zen, a skincare company built on a mission of authenticity, transparency, and giving back. Mei shares her personal journey from investor and philanthropist to entrepreneur, inspired by her search for truly natural skincare solutions and her father's legacy as an herbal doctor in Hong Kong. Together, James and Mei dive deep into the world of skincare ingredients, industry regulations, and why many products on the market don't meet the standards consumers deserve. Mei details how Ageless Zen's products are created with scientific rigor, natural ingredients, and minimal preservatives, emphasizing safety and efficacy while supporting non-profit initiatives like funding schools and cancer research. She pulls back the curtain on the challenges of sourcing rare ingredients, the complexities of creating shelf-stable, effective creams without harmful chemicals, and the thought behind her innovative, eco-friendly product packaging. Listen as Mei details how she started her skincare company and what she has learned throughout the process. Enjoy! Visit Mei at: https://agelesszen.com/ Podcast Overview: 00:00 Ageless Zen Skincare Startup 03:49 Journey to Natural Medicine Business 07:15 Creating a Pearl-Based Facial Cleanser 10:34 Expertise in Natural Ingredient Synergy 16:08 Natural Skincare Consciousness 18:44 "Natural Oil Soap Development Insight" 22:03 Consumer Empowerment Through Information 25:23 Seaberry's Unique Natural Benefits 28:04 "Balanced Topical Skincare Dosing" 31:35 Eco-Friendly Skincare Packaging 36:35 Night Cream with Peptide Matrix 38:28 Day vs. Night Creams Explained 41:36 Airtight, Eco-Friendly Bottle Design 45:45 "Exploring Natural Plant Benefits" 50:03 Nonprofit Empowerment & Fundraising Initiative 53:47 Focusing on Anti-Aging Skin Health 55:40 "Product Purchase and Community Support" Podcast Transcription: Mei Yung [00:00:00]: Well, interesting. That's a very interesting question you asked. And I think your listeners should also understand it too. FDA in America actually does not, you know, approve any product. They have a set of guidelines and they assume people will follow that guideline. And you build your product in the facility that is approved by the FDA and they can check the facility, all of that to make sure, you know, that everything is up to that particular standard. But mostly it's up to a skincare company to uphold it. And like, for example, I can tell you currently US company, you know, have about three or four hundred ingredients they're not allowed to use because they're toxic. Mei Yung [00:00:48]: They're highly sensitive like you said. But in Canada there's over a thousand or fifteen hundred that matter. Depends on where you look at. James Kademan [00:01:05]: You have found Authentic Business Adventures, the business program that brings you the struggle stories and triumphant successes of business owners across the land. Downloadable audio episodes can be found in the podcast link funded drawincustomers.com we are locally interwritten by the bank of Sun Prairie Calls on Call Extraordinary answering service as well as the Bold Business book. And today we're welcoming preparing to learn from Mei Young Lee, the founder and CEO of Ageless Zen. So May, how are you doing today? Mei Yung [00:01:36]: I am doing great in this beautiful Lake Tahoe. James Kademan [00:01:41]: Yeah, that's excellent. Glad to hear it. Thanks for being on the show. Why don't you start with the foundation? What is Ageless Zen? Mei Yung [00:01:49]: Well,
In this episode, hosts Kyle Kruse and Richard Meiklejohn are joined by Doug Evans, CEO of Lungpacer, to discuss innovative breakthroughs in respiratory care. Doug outlines the critical issue of mechanical ventilation, which affects 2 million patients annually in the U.S., with a 40% mortality rate among them. He provides detailed insights into how Lungpacer's neurostimulation technology aims to improve patient outcomes by maintaining diaphragm muscle function, thereby reducing time on ventilators and minimizing the need for reintubation. The discussion covers the rigorous research and FDA approval process, as well as the forthcoming Aero Nova system designed to assist patients from the onset of mechanical ventilation. Doug also shares the company's plans for commercialization, manufacturing scale-up, and future clinical milestones. The conversation highlights the potential impact of Lungpacer's technology on patient survival rates and healthcare costs, positioning it as a transformative solution in critical care, a story sure to leave you informed and inspired.
In this episode, Lisa interviews FDA Commissioner Marty Makary about his transition from medicine to government, emphasizing the need for transparency and accountability at the FDA. They discuss workforce reductions, stricter standards for COVID-19 vaccine approvals, expanded warnings about myocarditis, and efforts to eliminate synthetic dyes from food. Makary also highlights plans to modernize dietary guidelines and reduce animal testing. The Truth with Lisa Boothe is part of the Clay Travis & Buck Sexton Podcast - new episodes debut every Tuesday & Thursday. See omnystudio.com/listener for privacy information.
It's time for another episode of Ask Me Anything. Dawn and Ken answer listener questions that range from generative AI to whether grip strength is a biomarker for longevity and the potential of ketamine as a treatment for depression. Dawn also gives a brief overview of work she is doing with the deep-sea technology company Deep. As a special treat at the end of today's episode, Dawn plays a recording of the commencement speech that Ken recently gave at the University of West Florida. As the saying goes, you don't want to miss it. Show notes: [00:02:18] Ken starts off the episode with a listener question about whether Dawn and Ken read print books or digital, the reason being that a listener recently came across an article that claimed digital screens are rewiring our brains. [00:05:32] A listener asks about a paper titled “Grip Strength An Indispensable Biomarker for Older Adults” which claims that the ability to hang from a bar for 60 seconds for men, and 30 seconds for women, indicates that a person is likely to live longer. The paper claims that a decline in grip strength is associated with adverse health consequences, and the listener asks Ken what advice he has for developing and maintaining grip strength. [00:10:20] A listener asks a question inspired by our recent interview with Dr. Frank Butler. The listener asks if Ken has heard about the FDA approved depression therapy, esketamine, which is a derivative of ketamine and is a long-standing therapy for depression. [00:12:37] A listener asks Ken about a 2023 paper in the journal Age and Aging titled “Higher Dietary Protein Intake is Associated with Sarcopenia in Older British Twins” [00:16:13] A listener asks Ken about “Whisper,” which is a transcription product from OpenAI. The listener explains that OpenAI disclaims that Whisper should not be used in high-risk domains. However, according to a story by the Associated Press titled “Researchers Say an AI Powered Transcription Tool Used in Hospitals Invents Things No One Ever Said,” medical centers have already begun to use the tool to transcribe physician consultations. The listener explains that, according to the article, the use of Whisper in these contexts has led to numerous ‘hallucinations' from the AI tool and the listener asks Ken what his thoughts are on how tools like Whisper should be integrated into various industries. [00:20:21] A listener asks for Ken's thoughts on a series of articles by Kevin Roose in The New York Times claiming that there is no reason to learn how to code and program because very soon AI will take over all coding. Mr. Roose also asserts that the time is soon approaching when we need to have discussions on what rights to grant sentient AI. [00:21:57] A listener asks Ken if he concurs with a report from the National Academy of Medicine titled “Generative Artificial Intelligence in Health and Medicine – Opportunities and Responsibilities for Transformative Innovation,” which notes that large language models (LLMs) hold huge promise for patient care and healthcare system workflows, as well as risks. The listener asks if Ken agrees with the report's claims that two areas in which we could see near term applications of LLMs are patient education and synthesis of information of electronic medical records. [00:23:35] As a follow up question, Ken is asked about the aforementioned report's discussion of the “digital twin” concept. A digital twin is a computational representation of a patient or disease that could be used to speed up virtual experiments or subgroup analysis of investigational agents that carry risk for real patients. [00:26:26] A listener asks for Ken's thoughts on a paper published in the journal of Nutrition Health and Aging titled “Effects of Vitamin D3 Omega 3 Fatty Acids and a Simple Home Exercise Program on Change in Physical Activity Among Generally Healthy and Active Older Adults.” The paper claims that among generally healthy,
//The Wire//2300Z July 10, 2025////ROUTINE////BLUF: MERCHANT VESSELS SUNK IN RED SEA. FLOODING CONTINUES AROUND THE UNITED STATES.// -----BEGIN TEARLINE------International Events-Red Sea/HOA: Two commercial vessels have been sunk off the coast of Yemen by Houthi forces over the past few days. On July 6th, the M/V MAGIC SEAS was struck by cruise missiles and Unmanned Surface Vessels (USVs), which was rapidly followed up with small arms and RPG attacks via militants in small boats. The next day, the M/V ETERNITY C was attacked in a similar manner. Both vessels suffered severe flooding, finally sinking overnight.-HomeFront-Washington D.C. - This morning the FDA granted approval for Moderna's new "Spikevax" COVID-19 vaccine for children 6 months old to 11 years old. Following concerns expressed by the agricultural community, the USDA has reversed their stance on allowing cattle to be imported from Mexico. The decision to re-close livestock imports was made following a new infestation of New World Screwworm (NWS) being reported at a higher latitude than previously disclosed by Mexican officials, and that NWS was present in herds of livestock much closer to the US/Mexico border than previously known. As of right now, all ports of entry are closed to Mexican cattle, while the parasite continues to spread throughout Mexico.Southern USA: Flooding incidents remain constant as severe weather systems continue to develop throughout the region. More severe flooding was reported throughout North Carolina, with water rescues continuing in Durham and many downed trees causing power outages. The Graham–Mebane Water Treatment Plant went offline due to flooding damage, causing a brief water shortage throughout the city of Mebane.The flooding recovery in Texas continues as the total casualty count climbs to 120x fatalities and around 173x people still being unaccounted for. In New Mexico, 3x fatalities were reported as a result of the floods over the past few days, as flash floods struck the town of Ruidoso.-----END TEARLINE-----Analyst Comments: Heavy rain is still being forecast for many areas throughout the American South and along the east coast for the next few days. Considering the rain that has already fallen, in many areas the ground is already saturated, making flooding and landslides much more of a risk. Now is the time to prepare, and consider the impact of weather events becoming much more severe than originally forecast.Analyst: S2A1Research: https://publish.obsidian.md/s2underground//END REPORT//
This episode was recorded at the 2025 Petfood Forum in Kansas City, Missouri. Austin begins with an overview of the Association of American Feed Control Officials (AAFCO). Their membership consists of all government officials in the US and other countries who are charged by law to regulate animal feed, including pet food, in their jurisdictions. Canada, Costa Rica, and the US all participate in AAFCO. In the US, animal feed regulation is an integrated food safety system with a partnership between state and federal regulators as well as FDA. AAFCO's ultimate goal is to harmonize animal feed regulation across all states and provide a level playing field for the industry. (8:14)He goes on to explain that AAFCO and FDA's Center for Veterinary Medicine had a long-standing MOU in place that outlined an ingredient approval pathway that ended on October 1, 2024. FDA chose not to renew that MOU to focus on improving their other regulatory pathways, the Food Additive Petition Process and the Generally Regarded as Safe (GRAS) Notice Program. The FDA also has a new Animal Food Ingredient Consultation Process for ingredient approval. AAFCO has partnered with Kansas State University's Olathe Innovation Campus to scientifically review new ingredients, then bring them back through the AAFCO process to get formal approval. Ingredient companies can choose one of these four pathways for new ingredient approval. (10:05) Dr. Starkey notes that the process a company chooses will depend on the ingredient. If it's similar to ingredients proven safe on the market already, the KSU-AAFCO system would be a good route. If it's something a little more sophisticated or a new chemical, that may be more appropriate for a food additive petition, where toxicology studies would be conducted. (12:49)The panel discusses how scrutiny of GRAS rules might impact the pet food industry. Dr. Larson explains the scientific rigor involved in evaluating new ingredients. Dr. Starkey notes that there are different levels of GRAS, one of which is self-affirmed, which might be the one under the most scrutiny at this point. The panel agrees that transparency is critical for consumer confidence and ensuring health and safety of pets. (15:47)Austin talks about some of the ripple effects of the federal reduction in force in the regulatory arena. He and Dr. Larson talk about how the AAFCO-K-State partnership came to be, how K-State is ramping up to manage this project, and future plans for the partnership. (19:52)Dr. Starkey underlines the importance of timely ingredient approvals and how the new AAFCO-K-State partnership allows for companies to be more competitive due to the speed of approvals. Austin notes that an ideal submission with no follow-up questions or back-and-forth would have taken about 18 months to get approval under the old MOU between AAFCO and FDA, and a very small percentage of applications would be considered ideal. With the new AAFCO-K-State process, an expert panel reviews the submission in 60-90 days and the entire approval process is cut roughly in half, to about nine months. (25:55)Scott and the panel discuss how approval pathways differ for ingredient approval based on the claim being made. For example, is it a nutrient or is there some sort of pharmaceutical claim? (28:36)Panelists share their take-home thoughts. (37:19)Please subscribe and share with your industry friends to invite more people to join us at the Real Science Exchange virtual pub table. If you want one of our Real Science Exchange t-shirts, screenshot your rating, review, or subscription, and email a picture to anh.marketing@balchem.com. Include your size and mailing address, and we'll mail you a shirt.
Ep 218 |
Tune in as Glenn Hunzinger, PwC's Health Industries Leader, connects with Nick Donkar, PwC's U.S. Health Services Deals Leader, and Roel Van den Akker, PwC's Pharma and Life Sciences Deals Leader, to discuss the 2025 midyear deals outlook across health services and pharma and life sciences. They explore how macroeconomic trends, regulatory pressures, and evolving investment strategies are shaping M&A activity and where new opportunities may emerge as companies look ahead to the second half of the year. Discussion highlights: Health services deal volume remains resilient, with renewed investor interest in behavioral health, physician groups, and home-based care modelsPrivate equity firms are focused on outpatient growth platforms and niche services like revenue cycle management to navigate cost and regulatory headwindsPharma and life sciences dealmaking is centered on targeted, asset driven M&A in the $1 to $5 billion range, rather than full scale platform acquisitionsRegulatory uncertainty from FDA resource constraints to evolving policies on pricing and probability of technical and regulatory success (PTRS), is complicating deal modeling and slowing transaction timelinesU.S. biopharma companies are increasingly sourcing early stage innovation from China, introducing new strategic opportunities along with cross border compliance and data challengesSpeakers:Glenn Hunzinger, Health Industries Leader, PwCNick Donkar, US Healthcare Deals LeaderRoel Van den Akker, US Pharma & Life Sciences Deals Leader Linked materials:https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.htmlhttps://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.htmlFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Send us a textIn this episode, Dr. Eeks sits down with world-renowned cardiologist and nutrition dynamo Dr. Kim Williams to pull the lid off “healthy” plant-based restaurant meals, and a whole lot more.What's on the menu:First-of-its-kind restaurant study – How Dr. Williams scored plant-based dishes for heart health, what shocked him, and the sneaky “health halo” traps you'll now spot a mile away.Plant-based vs. junk-based – Could plant-based be sliding toward the same fate as the Western diet? He breaks down where things are headed and how to dodge the pitfalls.Cardio-nutrition deep dive – The eating plan Dr. Williams follows himself, plus straight talk on saturated fat, carbs, sugar, cholesterol, animal welfare, and factory farming.Big-picture fixes – Population-level policies he believes could actually move the needle on improving nutrition at the public health level.If you eat out, care about your heart, or just want the unvarnished science behind plant-powered plates, this episode is packed with gems you won't want to miss.Dr. Kim Allan Williams, MD, MACC, FAHA, MASNC, FESC is Chair of Medicine at the University of Louisville and a triple-threat in general, preventive, and cardiovascular-imaging cardiology. He's a former President of both the American College of Cardiology and the American Society of Nuclear Cardiology, and he previously led the Association of Black Cardiologists as Board Chair. At Wayne State he launched the Urban Cardiology Initiative, and later created Rush University's H.E.A.R.T. Program (Helping Everyone Assess Risk Today)—community screenings that pair education, nutrition, and lifestyle coaching. A lifelong advocate for nutrition literacy, health-equity, and system-wide reform, Dr. Williams has advised the FDA, CMS, and served more than 25 years as an AMA delegate. Most recently, he sat on the 2022 task force that briefed the White House Conference on Nutrition, Health, and Hunger.You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here! (Now featuring interviews with top experts on health you care about!)Support the show
“Very often, doctors try to suppress what they feel or don't even have the vocabulary to describe their emotions,” says Professor Alicja Galazka of the University of Silesia, an observation based on decades of work with physicians to enhance their emotional intelligence and resilience. Galazka, a psychotherapist, psychologist, lecturer and coach, believes this deficit is rooted in part in a lack of instruction in the internal and external psychological dimensions of being a medical provider. “There is not enough space created in medical school for teaching and training students about how to deal with their own stress and all of the skills connected to building relationships with patients,” she tells host Michael Carrese. Those same skills are also critical to working effectively as a member of a care team, which is an increasingly common arrangement in hospitals and clinics. Galazka employs simulations, dramatic role-playing, mindfulness, Acceptance and Commitment Therapy and other methods in her work with an eye on increasing the emotional agility and sensitivity of her trainees and clients. Tune in to this thoughtful episode of Raise the Line to hear Galazka's ideas on how to reshape medical training, why she is a proponent of narrative medicine, and the merits of embedding psychologists on care teams as a resource for both patients and providers. Mentioned in this episode:University of SilesiaInternational Association of Coaching Institutes If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
In this explosive and highly anticipated episode, Dr. Roger McFillin hosts Dr. Ragy Girgis, a Columbia University Professor of Psychiatry and researcher, for a no-holds-barred confrontation that exposes the shocking divisions tearing apart the mental health field. What begins as a conversation about mass violence research rapidly explodes into a devastating examination of psychiatric medicine's crumbling foundations, questionable effectiveness, and devastating potential harms. The two clash in fierce, unrelenting disagreements over fundamental issues including the validity of DSM diagnoses, the debunked "chemical imbalance" theory of depression, dangerous SSRI safety cover-ups and black box warnings, corrupted research quality and pharmaceutical industry manipulation, and the catastrophic crisis of psychiatric drug overprescription poisoning 1 in 4-5 Americans. Dr. Girgis desperately defends traditional academic psychiatry and current treatment approaches, while Dr. McFillin ruthlessly dismantles the entire paradigm, arguing that the current system is systematically creating chronic mental illness rather than healing it. Buckle up for this brutal intellectual warfare.___________________________________________________________________________________________________________________________________________________Throughout the interview, Dr. Girgis repeatedly stated that "the data is clear" while dismissing contradictory evidence that challenges his conclusions. For our listeners' benefit, I have compiled research and documentation that directly disputes several of Dr. Girgis's key claims.Serotonin Hypothesis of Depression1. The serotonin theory of depression: a systematic umbrella review of the evidence (Moncrieff et al.)Conclusions: "This review suggests that the huge research effort based on the serotonin hypothesis has NOT produced convincing evidence of a biochemical basis to depression. This is consistent with research on many other biological markers . We suggest it is time to acknowledge that the serotonin theory of depression is NOT empirically substantiated."2.What has serotonin to do with depression?Conclusions: "Simple biochemical theories that link low levels of serotonin with depressed mood are no longer tenable."3. Is the chemical imbalance an ‘urban legend'? An exploration of the status of the serotonin theory of depression in the scientific literatureViolence & Suicide Associated with SSRI's 1. Precursors to suicidality and violence on antidepressants: systematic review of trials in adult healthy volunteers2. Prescription Drugs Associated with Reports of Violence Towards Others3. Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family4. Lexapro Approved for Pediatric Use Despite the 6-Fold Increase in Suicide Risk5. McFillin Substack Review on Lexapro approved despite Suicide Risk6. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports7. Antidepressants Increase Suicide Attempts in Youth; No Preventative Effect8. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk:9. FDA Warning: Antidepressants increase the risk of suicidal thinking and behavior (suicidality) in children and adolescents10. Suicide Mortality in the United States, 2001–2021 CDC documentation11. US suicide rate reaches highest point in more than 80 years: See what latest data shows12. CNN article reporting Eli Lilly Internal Documents"An internal document purportedly from Eli Lilly and Co. made public Monday appears to show that the drug maker had data more than 15 years ago showing that patients on its antidepressant Prozac were far more likely to attempt suicide and show hostility than were patients on other antidepressants and that the company attempted to minimize public awareness of the side effects. The 1988 document indicated that 3.7 percent of patients attempted suicide while on the blockbuster drug, a rate more than 12 times that cited for any of four other commonly used antidepressants.In addition, the paper said that 1.6 percent of patients reported incidents of hostility -- more than double the rate reported by patients on any of four other commonly used antidepressants."Examples of Violence after Prescription in legal system (Sample)January 24, 2020 – Newcastle, South Dublin, Ireland: Deirdre Morley, 44, smothered and killed her two sons Conor, 9, and Darragh, 7, and her three-year-old daughter Carla McGinley in their family home. She had been taking antidepressants since October 2018 and was admitted to St. Patrick's Mental Health Services on July 6, 2019, but was discharged after a short period, but was put on a combination of two antidepressants and a sedativeMay 11, 2018 – Osmington, Western Australia: Peter Miles, 61, shot his 35-year-old daughter and four grandchildren, aged 8 through 13, while they slept in their beds, in a shed that had been converted to a second house on the property. He then turned the gun on his 58-year-old wife in the living room of their house, before placing a call to police alerting them to his crimes. When they arrived, Miles was also found dead from a gunshot wound. Miles had started taking antidepressant medication just weeks before.April 6, 2018 – Wadsworth, Ohio: Gavon Ramsay, 17, strangled his neighbor, 98-year-old Margaret Douglas in her own home. His parents blame his actions on his having been misprescribed Zoloft. After a report by his school principal that the teen was depressed and might harm himself, he “returned to therapy,” and after a recommendation by a psychologist, the family's pediatrician prescribed the antidepressant Zoloft. From January through March leading up to the incident, the dosages were increased. During this time, his mother said she observed her son's behavior change—becoming increasingly irritable and hostile and saying bizarre things.October 21, 2013 – Sparks, Nevada: 12-year-old Jose Reyes opened fire at Sparks Middle School, killing a teacher and wounding two classmates be...
We got two great guests for you this hump day. First, we talk to Brandon Roberts, an investigative journalist for ProPublica about the error prone AI program that DOGE implemented to determine Veterans Affairs cuts. We also discuss how FDA cuts have made it difficult to regulate the quality and safety of pharmaceuticals imported from other countries. Then we talk to Memo Torres an award-winning food and lifestyle Journalist and director of L.A. Taco who has been doing incredible work covering ICE's attacks on California. Check out their coverage here: L.A. TACO - Celebrating The Taco Lifestyle in Los Angeles. Also if you are in the LA area and you spot ICE agents in the wild notify L.A. Taco by emailing tips@lataco.com and they will spread the word. In the fun half we watch Hakeem Jeffries struggle to cope with the idea of getting primaried. Then we check in with Dave Rubin and his old boss, Glenn Beck. They provide some clarity on the future of the Democratic party and their plot to destroy the west. Become a member at JoinTheMajorityReport.com: https://fans.fm/majority/join Follow us on TikTok here!: https://www.tiktok.com/@majorityreportfm Check us out on Twitch here!: https://www.twitch.tv/themajorityreport Find our Rumble stream here!: https://rumble.com/user/majorityreport Check out our alt YouTube channel here!: https://www.youtube.com/majorityreportlive Gift a Majority Report subscription here: https://fans.fm/majority/gift Subscribe to the ESVN YouTube channel here: https://www.youtube.com/esvnshow Subscribe to the AMQuickie newsletter here: https://am-quickie.ghost.io/ Join the Majority Report Discord! https://majoritydiscord.com/ Get all your MR merch at our store: https://shop.majorityreportradio.com/ Get the free Majority Report App!: https://majority.fm/app Go to https://JustCoffee.coop and use coupon code majority to get 10% off your purchase Check out today's sponsors SHOPIFY: Sign up for a $1/month trial period at shopify.com/majority SUNSET LAKE: Use coupon code “Left Is Best” (all one word) for 20% off of your entire order at SunsetLakeCBD.com Follow the Majority Report crew on Twitter: @SamSeder @EmmaVigeland @MattLech Check out Matt's show, Left Reckoning, on YouTube, and subscribe on Patreon! https://www.patreon.com/leftreckoning Check out Matt Binder's YouTube channel: https://www.youtube.com/mattbinder Subscribe to Brandon's show The Discourse on Patreon! https://www.patreon.com/ExpandTheDiscourse Check out Ava Raiza's music here! https://avaraiza.bandcamp.com/ The Majority Report with Sam Seder – https://majorityreportradio.com/
Story at-a-glance Results of a two-year investigation found that the U.S. Food and Drug Administration (FDA) approved nearly 75% of new drugs between 2013 and 2022 without meeting its own basic standards Some cancer and Alzheimer's drugs were fast-tracked using surrogate markers like tumor shrinkage or protein levels, not real improvements in survival, memory, or function Dangerous side effects — including brain inflammation, hemorrhage, and blindness — were linked to drugs approved on minimal or flawed data, with thousands of deaths occurring each year The reporters created a searchable database on FDA drug approvals made between 2013 and 2022 — use it to check if any of your prescriptions meet the four scientific standards Always ask if a drug shows real-world benefits, look up its approval history, wait on new drugs, review your prescriptions, and work with a doctor who questions the system
On this episode of Vitality Radio, Jared shares three powerhouse supplements that may not be “new,” but are being used in some of the most impactful ways yet. First up is a clinically studied lutein and zeaxanthin complex that supports eye health, blue light protection, and even cognitive performance—delivered in a delicious gummy called Screen Eyes. Next, Jared breaks down monolaurin, a coconut-derived compound that supports immune resilience by targeting lipid-coated viruses like herpes, Epstein-Barr, and influenza—especially when paired with L-lysine and vitamin C. And finally, he explores two innovative magnesium-based powders from Kal - Clean Out Magnesium and Gut Magnesium, each designed to promote healthy regularity and support cleansing protocols. If you've struggled with constipation or want to fine-tune your immune and visual wellness, this is an episode you don't want to miss.Products:Zhou Screen Eyes Blue Light FormulaMonolaurin & LysineVital-C ImmunityNano-SilverKAL Clean Out Magnesium PowderKAL Gut Magnesium PowderVital 5 Magnesium BisglycinateAdditional Information:#209 VR Short: Centrum SucksVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
In this new conversation, Dr. Robert Malone and Rav Arora discuss the complexities surrounding vaccine authorization, the divisions within MAHA, the implications of FDA policies, and the recent MAHA Commission report. They emphasize the need for a nuanced understanding of vaccine efficacy and the political dynamics influencing public health decisions. The discussion also touches on the future of vaccines, the importance of advocacy, and the challenges faced in the regulatory landscape.The Illusion of Consensus is a reader-supported publication. To receive new posts and support my work, consider becoming a paid subscriber:Links:Spotify / Apple(Up on all video platforms in 48 hours)Chapters:00:00 Introduction and Personal Updates02:49 Exploring the SplinterNet and Video Streaming Opportunities05:52 The Dynamics of Content Creation and Monetization08:19 The State of Health Agencies and Political Landscape11:27 Challenges and Opportunities in the Maha Agenda39:37 The Evolution of the Maha Organizations42:20 Bobby Kennedy's Strategic Challenges44:58 Divisions Within the Vaccine Debate49:02 Political Strategies and Public Perception53:51 Navigating Regulatory Challenges58:23 Recent Developments in Vaccine Policy01:14:52 Insights from the Maha Commission Report01:17:39 Navigating Controversies in Health Policy01:20:27 The Role of Key Figures in Health Advocacy01:23:29 Insights from the Maha Report01:28:26 Populism and Policy Implementation Challenges01:34:57 The Future of Health Initiatives and Advocacy01:42:21 Understanding New Vaccine DevelopmentsSupport The Illusion of Consensus!The Illusion of Consensus is a fully reader-supported publication. I need your support now more then every as I launch the new season of the show this week. If you support the high-quality science and Big Pharma journalism on this site, consider becoming a paid or founding member to receive exclusive articles, early-access episodes, and ask questions for future episodes. Or support The Illusion of Consensus with a one-time donation. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.illusionconsensus.com/subscribe
Jackie takes up pickling, shoots up at a child's birthday party in the park, and goes over her tour packing-list that will almost certainly get Josh searched by the TSA.Thanks for supporting my sponsors!Nutrafol: Get $10 off your first month's subscription and free shipping when you enter the promo code BIBLE at www.Nutrafol.comHomes.com: Everything you need to know about buying a house, all in one place www.Homes.comHero Bread: Use code JACKIE at checkout to get 10% off your order at www.Hero.coSKIMS: Shop my favorite bras and underwear at www.skims.com/bible #skimspartnerAddyi: Check out the FDA-approved treatment for certain premenopausal women who are bothered by low libido and want their sex drive back at www.Addyi.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
GLP-1 medications like Ozempic have dominated headlines over the past couple of years. When writing his new book, Diet, Drugs and Dopamine: The New Science of Achieving a Healthy Weight, former FDA commissioner David Kessler wanted to unpack the science beyond those headlines. He also has a personal relationship with the subject, having taken GLP-1 medications himself. Host Flora Lichtman joins Kessler to talk about the latest science on metabolism, weight loss, and how these blockbuster drugs actually work.Guest: Dr. David Kessler is the former commissioner of the FDA and the author of Diet, Drugs and Dopamine: The New Science of Achieving a Healthy Weight.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
According to online commentator Candace Owens, President Donald Trump personally called her to pressure her into stopping her coverage of allegations involving Brigitte Macron's gender. Trump was reportedly concerned that Owens' reporting could harm negotiations to end the Ukraine war, although Jimmy and Americans' Comedian Kurt Metzger wonder how the first lady of France's penis or the lack thereof could affect delicate ceasefire negotiations. The call reportedly occurred amid growing controversy surrounding the allegations, highlighting Trump's willingness to use direct influence to control media messaging. Owens says she told the president that it's not her fault Macron married someone with a penis. Plus segments on the recent CDC announcement that mercury would be removed from all vaccines, the FDA expanding the warning labels on COVID vaccines and Trump's plans to prosecute CNN employees for covering the release of an app that tracks ICE agents. Also featuring Mary Holland, Stef Zamorano and Mike MacRae. And a phone call from JD Vance!
Story at-a-glance More than 1 in 4 rice products sold in the U.S. now exceed the FDA's arsenic limit for infant cereal, exposing families to heavy metals that harm brain development, kidneys and long-term health Brown rice grown in the southeastern U.S. was the most contaminated, while white basmati from India, Thai jasmine and California-grown white rice had the lowest heavy metal levels Cooking rice in extra water and draining it like pasta cuts arsenic exposure by up to 60%, making it one of the simplest ways to reduce your toxic load Children under 2 in Asian American and Latino households are exposed to two to four times more arsenic from rice than the general population due to higher rice consumption White rice is easier to digest and less inflammatory than brown rice for people with gut issues or mitochondrial dysfunction, making it a better choice for many; choosing lower-contaminated varieties and cooking them properly are key
© 2020-2025 Ivy Podcast Discovery LLC
